Results from a phase II proof of concept trial of VSN16R to treat multiple sclerosis related spasticity (2018)

First Author: Farrell R.

Attributed to: Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug funded by MRC

No abstract provided

Type: Conference/Paper/Proceeding/Abstract

Volume: 24

Parent Publication: MULTIPLE SCLEROSIS JOURNAL

ISSN: 1352-4585